Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
PON1 modulation may curb LDL oxidation; leaves open clinical translation to cardiovascular outcomes.
High-density lipoprotein (HDL) provides a pathway for the passage of lipid peroxides and lysophospholipids to the liver via hepatic scavenger receptors. Perhaps more importantly, HDL actually metabolizes lipid hydroperoxides preventing their accumulation on low-density lipoprotein (LDL), thus impeding its atherogenic structural modification. A number of candidates have been suggested to be responsible for HDL's antioxidant function, with paraoxonase-1 (PON1) perhaps the most prominent. Here we review the evidence for HDL anti-oxidative function and the potential contributions of apolipoproteins, lipid transfer proteins, paraoxonases and other enzymes associated with HDL.
No takes yet. Share an insight, caveat, or question.
Soran et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: